维普中文期刊产品整合服务
23篇 您的检索式:作者名="LAVOUE V"
    题名 作者 年代 出处 被引量
1SH2DIA mutation analysis for diagnosis of XLP in typical and atypical patients显示文摘Yin L Ferrand V Lavoue MF 1999Hum Genet1999,105,:1
2Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer显示文摘Lavoue V Thedrez A Leveque J 2013J Transl Med2013,11,:1
3Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer显示文摘Sardain H Lavoue V Laviolle B 2014Int J Gynecol Caneer2014,24,9:1
4Immunity of human epithe- lial ovarian carcinoma: the paradigm of immune suppression in cancer显示文摘Lavoue V Thedrez A Leveque J 2013J Transl Med2013,11,:1
5Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer显示文摘Lavoue V Thedrez A Leveque J 2013J TranslMed2013,11,1:1
6External valida- tion of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing in- terval debulking surgery 显示文摘Chereau E Lavoue V Ballester M 2011Anticancer Res2011,31,12:1
7Externalvalidation of a laparoscopic-based score to evaluateresectability for patients with advanced ovarian cancerundergoing interval debulking surgery 显示文摘Chereau E Lavoue V Ballester M 2011AnticancerRes2011,31,12:1
8Contribution of the sentinel node procedure to tailoring the radicality of hysterectomy for cervical cancer显示文摘Darai E Lavoue V Rouzier R 2007Gynecol Oncol2007,106,1:1
9Impact of robotics on the outcome of elderly patients with endometrial cancer 显示文摘Lavoue V Zeng X Lau S 2014Gynecol Oncol2014,133,3:1
10Immunity of human epithelial ovarian carcinoma:the paradigm of immune suppression in cancer显示文摘Lavoué V Thédrez A Levêque J 2013J Transl Med2013,11,1:1
11Curative pelvic exentera- tion for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy: a systematic review 显示文摘Sardain H Lavoue V Redpath M 2015Eur J Surg Oncol2015,41,8:1
12Occurrence of endometrial cancer six years after treatment with thermal balloon ablation (Thermachoice): first case report 显示文摘Le Marrec A Lavoue V Morcel K 2010Eur J Obstet Gynecol Reprod Biol2010,150,2:1
13External validation of a laparoscopic-based score to evaluate resectability for patients with advanced ovarian cancer undergoing interval debulking surgery 显示文摘Chereau E Lavoue V Ballester M 2011Antieancer Research2011,31,12:1
14Immunity of humanepithelial ovarian carcinoma:the paradigm of immune suppressionin cancer显示文摘LAVOUE V THEDREZ A LEVEQUE J 2013J Transl Med2013,11,:1
15Aminobisphosphonate?pretreated dendritic cells trigger successful V gamma 9V delta 2 T cell amplification for immunotherapy in advanced cancer patients显示文摘Cabillic F Toutirais 0 Lavoue V 2010Cancer Immunology Immunotherapy2010,59,:1
16Impact of robotics on the out- come of elderly patients with endometrial cancer显示文摘Lavoue V Zeng X Lau S 2014Gynecol On- col2014,133,3:1
17Management of lobular neoplasia surgical excision显示文摘Lavoue V Graesslin O Classe JM 2007Breast2007,16,5:1
18Curative pelvic exentera- tion for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy: a systematic review 显示文摘Sardain H Lavoue V Redpath M 2015Eur J Surg Oncol2015,41,8:1
19External validation of a laparo- scopic-based score to evaluate resectability for patients with advanced o- varian cancer undergoing interval debulking surgery显示文摘Chereau E Lavoue V Ballester M 2011Anticancer Res2011,31,12:1
20Contribution of the sentinel node procedure to tailoring the radicality of hysterectomy for cervical cancer显示文摘Darai E Lavoue V Rouzier R 2007Gynecol Oncol2007,106,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费